Green Cross LabCell-Green Cross Cell Integrated Corporation 'GC Cell' Officially Launched

GC Cell English and Korean logos (Photo by GC Cell)

[Asia Economy Reporter Chunhee Lee] The integrated corporation of GC LabCell and GC Cell, 'GC Cell,' is officially launching.

On the 2nd, GC LabCell and GC Cell announced the issuance report of securities and announced the launch of the integrated corporation GC Cell. The day before, both companies held a board meeting and completed the merger completion report. The stock market is scheduled to change the stock name to GC Cell on the 17th.

GC Cell cites the greatest synergy from the merger as the organic combination and utilization of GC LabCell's cell therapy research and process technology with GC Cell's manufacturing capabilities. In the field of immune cell therapy, which both companies are commonly developing, they plan to secure pipelines across all areas including T, NK, CAR-T, and CAR-NK, aiming to create a complete form in the cell therapy sector. Additionally, expansion in the rapidly growing Contract Development and Manufacturing Organization (CDMO) sector is also expected.

Park Dae-woo, CEO of GC Cell, said, “The integrated corporation will expand into the global market through the mission of contributing to humanity's healthy life and the new vision of ‘Global Cell Therapy Bio-Tech Solution Pioneer,’ aiming to become a ‘First in Class Bio Tech’ company. We will transform the integrated corporation into a global standard-based global leader in cell therapy by enhancing organizational structure, human resources, work methods, and infrastructure.”

This content was produced with the assistance of AI translation services.